Click here to read the full article.
The prestigious British Medical Journal (BMJ) has called the American model of gender-affirming care for minors not “evidence-based” and at risk of harming young people through “overtreatment,” leading some trans activists to make accusations of transphobia and alarmism.
An investigation by The BMJ found that more and more young people in the US are being offered medical and surgical sex change interventions, sometimes bypassing psychological assessment and counselling, said BMJ Editor-in-Chief Kamran Abbasi in an article published March 9.
According to Abbasi, this practice of immediate affirmation and placing children straight onto a medical pathway involving puberty blockers and cross-sex hormones is supported by guidance from medical societies and associations, but he reports that a closer inspection of such guidance reveals the strength of the clinical recommendations “is not in line with the strength of the evidence.”
“The risk of over treatment is real,” Abbasi stressed.
The American Academy of Pediatrics (AAP) has been ignoring calls to justify its decision to endorse gender-affirming care for minors in its 2018 position statement. According to sexologist James Cantor, the AAP statement, drawn up by an activist subcommittee misrepresented entire literatures and the authors “told neither the truth nor the whole truth, committing sins of commission and omission, asserting claims easily falsified by anyone caring to do any fact-checking at all.”
Abbasi points to the evidence presented by Dr. Hilary Cass last year in her interim report of the independent review of the England’s pediatric gender service. Her findings question the evidence for affirmation, puberty blockers and cross-sex hormones and the final report due later this year is expected to recommend a focus on psychological support for this vulnerable cohort of young patients.
Continue reading here.
Scroll down for comments and share your thoughts!
GIPHY App Key not set. Please check settings